Abbott Laboratories (Pakistan) Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was PKR 12,909.27 million compared to PKR 10,907.19 million a year ago. Revenue was PKR 12,909.27 million compared to PKR 10,907.19 million a year ago. Net income was PKR 338.23 million compared to PKR 1,839.5 million a year ago. Basic earnings per share from continuing operations was PKR 3.45 compared to PKR 18.79 a year ago.
For the six months, sales was PKR 24,680.43 million compared to PKR 20,797.98 million a year ago. Revenue was PKR 24,680.43 million compared to PKR 20,797.98 million a year ago. Net income was PKR 1,780.01 million compared to PKR 3,281.99 million a year ago. Basic earnings per share from continuing operations was PKR 18.18 compared to PKR 33.52 a year ago.